VNOV · VitaNova Life Sciences Corp · Documents
Market Cap
$33.77M
Shares
8.34M
Volume · Oct 20
385
Avg daily vol (7 sessions)
339
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2026-09-14 | 2026-07-31 | |
| 10-K | — | 2026-07-29 | 2026-04-30 | |
| 8-K | — | 2026-03-18 | 2026-03-12 | |
| 10-Q | — | 2026-03-16 | 2026-01-31 | |
| 8-K | — | 2026-02-25 | 2026-02-19 | |
| 8-K | — | 2026-01-27 | — | |
| 8-K | — | 2026-01-13 | 2026-01-09 | |
| 10-Q | — | 2025-12-15 | 2025-10-31 | |
| 8-K | — | 2025-10-07 | — | |
| 10-Q | — | 2025-09-12 | 2025-07-31 | |
| 10-K | — | 2025-07-24 | 2025-04-30 | |
| 10-Q | — | 2025-03-17 | 2025-01-31 | |
| 10-Q | — | 2024-12-13 | 2024-10-31 | |
| 10-Q | — | 2024-09-10 | 2024-07-31 | |
| 10-K | — | 2024-07-29 | 2024-04-30 | |
| 8-K | — | 2024-06-10 | 2024-06-05 | |
| 10-Q | — | 2024-03-11 | 2024-01-31 | |
| 8-K | — | 2024-02-05 | 2024-01-30 | |
| 8-K | — | 2024-01-12 | 2024-01-08 | |
| 10-Q | — | 2023-12-15 | 2023-10-31 | |
| 8-K | — | 2023-09-14 | 2023-09-12 | |
| 10-Q | — | 2023-09-14 | 2023-07-31 | |
| 8-K | — | 2023-06-15 | 2023-06-14 | |
| 10-K | — | 2023-05-15 | 2023-04-30 | |
| 10-Q | — | 2023-02-16 | 2023-01-31 | |
| 10-Q | — | 2022-11-14 | 2022-10-31 | |
| 10-Q | — | 2022-09-01 | 2022-07-31 | |
| 10-K | — | 2022-05-16 | 2022-04-30 | |
| 10-Q | — | 2022-02-17 | 2022-01-31 | |
| 8-K | — | 2022-02-16 | 2021-07-31 | |
| 8-K | — | 2021-12-02 | 2021-11-30 | |
| 10-Q | — | 2021-11-10 | 2021-10-31 | |
| 10-Q | — | 2021-08-20 | 2021-07-31 | |
| 8-K | — | 2021-08-05 | 2021-07-28 | |
| 10-K | — | 2021-07-01 | 2021-04-30 | |
| 10-Q | — | 2021-06-21 | 2021-01-31 | |
| 8-K | — | 2021-06-11 | 2021-06-09 | |
| 8-K | — | 2021-06-01 | 2021-05-25 | |
| 10-Q | — | 2020-11-25 | 2020-10-31 | |
| 10-Q | — | 2020-09-18 | 2020-07-31 | |
| 10-K | — | 2020-08-05 | 2020-04-30 | |
| 10-Q | — | 2020-03-20 | 2020-01-31 |
Showing 1–42 of 42 filings
Key facts
CIK
1699709